Form 4 for MRKR Marker Therapeutics, Inc.
Accepted 2023-06-08 00:00:00 ET · period of report 2021-03-16 · accession 0001209191-23-035617 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2023-06-08 | 2021-03-25 | MRKR | Eansor Norman David | Dir | G - Gift | $0.00 | +14.3K | 7,142 | New | $0 |
| D | 2023-06-08 | 2021-03-25 | MRKR | Eansor Norman David | Dir | G - Gift | $0.00 | -14.3K | 2,428 | -85% | $0 |
| D | 2023-06-08 | 2021-03-16 | MRKR | Eansor Norman David | Dir | P - Purchase | $17.50 | +14.3K | 16.7K | +588% | +$250.0K |
| D | 2023-06-08 | 2023-06-06 | MRKR | Eansor Norman David | Dir | A - Grant | $0.00 | +8,000 | 8,000 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-03-25 | G | A | 7,142 | $0.00 | 7,142 | I | — | — | (F1) Reflects a 10-1 reverse stock split which became effective on January 16, 2023. (F2) The Reporting Person transferred these shares to a trust of which the Reporting Person is the trustee. The Reporting Person's immediate family is the sole beneficiary of the trust. |
| 2 | Common | Common Stock | 2021-03-25 | G | D | 14,285 | $0.00 | 2,428 | D By the Scott Eansor 2020 Exempt Trust | — | — | (F2) The Reporting Person transferred these shares to a trust of which the Reporting Person is the trustee. The Reporting Person's immediate family is the sole beneficiary of the trust. (F1) Reflects a 10-1 reverse stock split which became effective on January 16, 2023. |
| 3 | Common | Common Stock | 2021-03-25 | G | A | 7,142 | $0.00 | 7,142 | I | — | — | (F1) Reflects a 10-1 reverse stock split which became effective on January 16, 2023. (F2) The Reporting Person transferred these shares to a trust of which the Reporting Person is the trustee. The Reporting Person's immediate family is the sole beneficiary of the trust. |
| 4 | Common | Common Stock | 2021-03-16 | P | A | 14,285 | $17.50 | 16,713 | D By the John R. Eansor 2020 Exempt Trust | — | — | (F1) Reflects a 10-1 reverse stock split which became effective on January 16, 2023. |
| 5 | Derivative | Stock Option (right to buy) | 2023-06-06 | A | A | 8,000 | $0.00 | 8,000 | D | $1.72 · — to 2033-06-05 | 8,000 Common Stock | (F3) This option vests on June 6, 2024, subject to the Reporting Person's continued service as a director through the vesting date. |